These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 2297700

  • 1. Tumor necrosis factor in children with malignancies.
    Saarinen UM, Koskelo EK, Teppo AM, Siimes MA.
    Cancer Res; 1990 Feb 01; 50(3):592-5. PubMed ID: 2297700
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T.
    Int J Hematol; 1993 Apr 01; 57(2):147-52. PubMed ID: 8494993
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha in malignant disease.
    Abrahamsson J, Carlsson B, Mellander L.
    Am J Pediatr Hematol Oncol; 1993 Nov 01; 15(4):364-9. PubMed ID: 8214357
    [Abstract] [Full Text] [Related]

  • 4. Serum interleukin-1 and tumor necrosis factor activities in febrile children with acute leukemia.
    Ishii E, Ohga S, Ueda K, Akazawa K.
    Int J Hematol; 1991 Feb 01; 54(1):79-84. PubMed ID: 1954355
    [Abstract] [Full Text] [Related]

  • 5. [Tumor necrosis factor alpha activity in peripheral blood in patients with acute leukemia: changes and clinical implications].
    Zeng B.
    Zhonghua Yi Xue Za Zhi; 1992 Jul 01; 72(7):405-7, 446. PubMed ID: 1330229
    [Abstract] [Full Text] [Related]

  • 6. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
    Dincaslan HU, Yavuz G, Unal E, Tacyildiz N, Ikinciogullari A, Dogu F, Guloglu D, Yuksek N, Ertem U.
    Pediatr Hematol Oncol; 2010 Oct 01; 27(7):503-16. PubMed ID: 20677920
    [Abstract] [Full Text] [Related]

  • 7. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F, Ertem U, Taçyildiz N, Kirazli S.
    J Med; 1995 Oct 01; 26(5-6):241-52. PubMed ID: 8721901
    [Abstract] [Full Text] [Related]

  • 8. Concentration of IL-2, IL-6, IL-8, IL-10 and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy.
    Mazur B, Mertas A, Sońta-Jakimczyk D, Szczepański T, Janik-Moszant A.
    Hematol Oncol; 2004 Mar 01; 22(1):27-34. PubMed ID: 15152368
    [Abstract] [Full Text] [Related]

  • 9. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
    Lin M, Meng X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 May 01; 20(5):245-8. PubMed ID: 11601213
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
    Müller HL, Oh Y, Lehrnbecher T, Blum WF, Rosenfeld RG.
    J Clin Endocrinol Metab; 1994 Aug 01; 79(2):428-34. PubMed ID: 7519190
    [Abstract] [Full Text] [Related]

  • 11. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
    Wu S, Korte A, Gessner R, Henze G, Seeger K.
    Cancer; 2003 Aug 01; 98(3):625-31. PubMed ID: 12879482
    [Abstract] [Full Text] [Related]

  • 12. [Does beta-2 microglobulin measurement play role in diagnostics of childhood malignancies?].
    Bień E, Balcerska A, Ciesielski D.
    Wiad Lek; 2004 Aug 01; 57(1-2):8-11. PubMed ID: 15181741
    [Abstract] [Full Text] [Related]

  • 13. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A, Wang JT, Chia JS, Chiang CP.
    J Oral Pathol Med; 2006 Feb 01; 35(2):111-6. PubMed ID: 16430742
    [Abstract] [Full Text] [Related]

  • 14. Clinical implications of telomerase activity levels in acute leukemia.
    Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K, Shay JW.
    Clin Cancer Res; 1997 Apr 01; 3(4):619-25. PubMed ID: 9815729
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-alpha and interleukin-6 profiles in children with pneumonia.
    Wang CM, Tang RB, Chung RL, Hwang BT.
    J Microbiol Immunol Infect; 1999 Dec 01; 32(4):233-8. PubMed ID: 10650487
    [Abstract] [Full Text] [Related]

  • 16. [Serum lysozyme level in children with acute leukemia and malignant diseases].
    Dick W, Dopfer R.
    Padiatr Padol; 1985 Dec 01; 20(1):25-32. PubMed ID: 3856210
    [Abstract] [Full Text] [Related]

  • 17. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M, Estrov Z, Talpaz M, Kim KJ, Alphonso M, Srinivasan R, Kurzrock R.
    Cancer Res; 1994 Apr 01; 54(7):1837-42. PubMed ID: 8137298
    [Abstract] [Full Text] [Related]

  • 18. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation.
    Haas R, Gericke G, Witt B, Cayeux S, Hunstein W.
    Exp Hematol; 1993 Jan 01; 21(1):109-13. PubMed ID: 7678083
    [Abstract] [Full Text] [Related]

  • 19. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J, Zhao Q, Yao H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar 01; 23(3):158-60. PubMed ID: 11778489
    [Abstract] [Full Text] [Related]

  • 20. Intrinsic capacity of monocytes to produce cytokines ex vivo in patients with acute lymphoblastic leukaemia.
    de Bont ES, Kimpen JL, Tamminga RY, Niemarkt AE, de Leij LH, Kamps WA.
    Cytokine; 2000 Nov 01; 12(11):1723-6. PubMed ID: 11052826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.